IO Biotech is listed on the portfolio pages of Eurazeo (portfolio page) and Vivo Capital (portfolio page). Eurazeo and Vivo Capital list it as current. Eurazeo has owned IO Biotech since 2021, per Eurazeo's portfolio page.
IO Biotech is a Healthcare company. Its owner on record, Eurazeo, is a buyout firm founded in 2001, headquartered in Paris, France, with €35 billion under management. Eurazeo lists 266 companies in the index, 34 of them in Healthcare. Also backed by Vivo Capital.
Eurazeo is a leading French private equity firm and investment group that manages a diversified portfolio of over 600 companies.
Read the Eurazeo profileHealth-care focused investment firm.
Read the Vivo Capital profileIO Biotech is listed on the portfolio pages of Eurazeo (portfolio page) and Vivo Capital (portfolio page). Eurazeo and Vivo Capital list it as current. Eurazeo has owned IO Biotech since 2021, per Eurazeo's portfolio page.
IO Biotech is in Healthcare. Classified from the owner's portfolio label.
Eurazeo is headquartered in Paris, France.
Eurazeo lists 33 other Healthcare companies in the index, including 3P Biopharmaceuticals, Amolyt Pharma, Bioserenity, C2S and Cardiologs Technologies.
6 of 265 shown
See the full Eurazeo portfolio.
6 of 97 shown
See the full Vivo Capital portfolio.
Browse PE-backed companies.
